Egypt vs Madagascar: Antiretroviral therapy coverage for PMTCT
Egypt
27.0%
in 2024
Madagascar
30.0%
in 2024
Egypt rank
79th
Madagascar rank
77th
Antiretroviral therapy coverage for PMTCT over time
- Egypt
- Madagascar
How they compare
Madagascar currently reports 30.0% against 27.0% in Egypt, a difference of 3.0%.
That makes Madagascar's figure about 1.1 times Egypt's.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Madagascar ahead.
Egypt ranks 79th and Madagascar ranks 77th of 84 countries.
Across the 3 decades both report, Egypt averaged higher in 2 and Madagascar in 1.
Head to head by decade
| Decade | Egypt | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 1.1% | 0.4% | Madagascar |
| 2010s | 9.7% | 7.8% | 1.9% | Egypt |
| 2020s | 25.2% | 21.4% | 3.8% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Egypt or Madagascar?
- Madagascar, at 30.0% against 27.0% in Egypt as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Egypt and Madagascar?
- 3.0%, with Madagascar ahead.
- How many years of comparable data are there for Egypt and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and Madagascar rank globally for antiretroviral therapy coverage for pmtct?
- Egypt ranks 79th and Madagascar ranks 77th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).